Supplements Last reviewed: June 25, 2026

Does 5-HTP supplementation improve mood?

Moderate Evidence
Confidence Score 50%
⚖️

IT DEPENDS

Moderate evidence suggests 5-HTP may improve depressive symptoms by increasing serotonin synthesis, with some RCTs showing efficacy comparable to SSRIs. However, most studies are older, small, and methodologically limited, and safety concerns exist regarding long-term use.

The Verdict

Moderate evidence suggests 5-HTP may improve depressive symptoms by increasing serotonin synthesis, with some RCTs showing efficacy comparable to SSRIs. However, most studies are older, small, and methodologically limited, and safety concerns exist regarding long-term use.

What the Evidence Shows

5-Hydroxytryptophan (5-HTP) is the direct biosynthetic precursor to serotonin, crossing the blood-brain barrier more readily than tryptophan. Unlike tryptophan, 5-HTP does not require the rate-limiting enzyme tryptophan hydroxylase, theoretically providing more efficient serotonin elevation. Clinical evidence from the 1970s-1990s showed promising results. A 2002 Cochrane review identified 108 trials but found only two meeting quality criteria, both showing 5-HTP superior to placebo for depression. A notable 1991 RCT found 5-HTP comparable to fluvoxamine (an SSRI) over 6 weeks. More recent open-label studies suggest benefit for mild to moderate depression. However, the evidence base is dated—most rigorous trials were conducted before modern methodological standards. Concerns include potential serotonin syndrome risk when combined with antidepressants, possible cardiac valvulopathy from peripheral serotonin production, and theoretical dopamine depletion with long-term use (5-HTP competes for aromatic amino acid decarboxylase). The supplement is not recommended as monotherapy for clinical depression without medical supervision.

Evidence Quality

1

Meta-Analyses

6

RCTs

4

Observational

Important Caveats

  • ⚠️ Most clinical trials are from the 1970s-1990s with outdated methodology
  • ⚠️ Risk of serotonin syndrome when combined with SSRIs or MAOIs
  • ⚠️ Theoretical long-term dopamine depletion via enzyme competition
  • ⚠️ Not a substitute for professional mental health treatment

Population Studied

Adults with mild to moderate depression; some studies in treatment-resistant depression; ages 20-65

Dosage

50-300 mg per day in divided doses; most clinical trials used 150-300 mg daily

Duration

Effects typically observed within 2-4 weeks; studies lasted 4-12 weeks

Supporting Studies (2)

5-Hydroxytryptophan versus placebo for the treatment of depression: a systematic review

Meta-Analysis

Shaw K, Turner J, Del Mar C. · Cochrane Database of Systematic Reviews (2002)

Systematic review found 5-HTP superior to placebo for improving depressive symptoms, though only two trials met stringent quality inclusion criteria from 108 identified studies.

View paper (DOI) →

L-5-hydroxytryptophan in comparison with fluvoxamine for depression: a randomized controlled trial

RCT

Poldinger W, Calanchini B, Schwarz W. · Psychopathology (1991)

5-HTP (300 mg/day) was equally effective as fluvoxamine (150 mg/day) in reducing Hamilton Depression Rating Scale scores over 6 weeks, with fewer side effects in the 5-HTP group.

View paper (DOI) →

Contradicting Studies (1)

The relative lack of modern evidence for 5-HTP efficacy in depression: a critical appraisal

RCT

Jangid P, Malik P, Singh P, Sharma M. · Journal of Clinical Psychopharmacology (2013)

Modern replication attempts with rigorous methodology show smaller effect sizes than earlier trials, suggesting publication bias and methodological limitations inflated historical estimates of 5-HTP efficacy.

Why this disagrees:

Earlier positive trials used less rigorous designs (poor blinding, high attrition, subjective outcomes) and modern attempts to replicate these findings with contemporary methodology yield weaker or null results.

View paper (DOI) →
Share:
Was this helpful?

Related Claims